Home
>
National Drug Code (NDC)
>
Lopid
Lopid - 0071-0737-20 - (gemfibrozil)
Drug Information of Lopid
| Product NDC: | 0071-0737 |
| Proprietary Name: | Lopid |
| Non Proprietary Name: | gemfibrozil |
| Active Ingredient(s): | 600 mg/1 & nbsp; gemfibrozil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lopid
| Product NDC: | 0071-0737 |
| Labeler Name: | Parke-Davis Div of Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018422 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20040330 |
Package Information of Lopid
| Package NDC: | 0071-0737-20 |
| Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (0071-0737-20) |
NDC Information of Lopid
| NDC Code | 0071-0737-20 |
| Proprietary Name | Lopid |
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (0071-0737-20) |
| Product NDC | 0071-0737 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | gemfibrozil |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20040330 |
| Marketing Category Name | NDA |
| Labeler Name | Parke-Davis Div of Pfizer Inc |
| Substance Name | GEMFIBROZIL |
| Strength Number | 600 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [Chemical/Ingredient] |
